Latest News and Press Releases

FDA written feedback supports: - a single-arm, open-label registrational trial in 2nd-line refractory high-grade NMIBC with CIS - a randomized vs observation single trial in intermediate-risk NMIBC...

TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) provides a corporate update highlighting progress on strategic...

ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in psoriasis and quarterly dosing in hidradenitis suppurativa Phase 2 studies for...

Autolus announced preliminary unaudited net product revenue from sales of AUCATZYL® (obe-cel) for the fourth quarter and full year of 2025.

Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform

North America Comparable Sales Increase 6.5%Adjusting Fourth Quarter Outlook Including Raising EPS Guidance LYNNWOOD, Wash., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Zumiez Inc. (NASDAQ: ZUMZ) a leading...

On track to report interim results from approximately 25 six-month evaluable BCG-Unresponsive patients in ADVANCED-2 trial in Q1 2026 Received Breakthrough Therapy and Fast Track designations for...

BROOMFIELD, Colo., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq: NDLS) today released preliminary, unaudited sales results for the fourth fiscal quarter ended December 30, 2025. ...

Agios today announced its 2026 strategic priorities and key milestones anticipated during the year.

GREENWICH, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) will hold its fourth quarter and full-year 2025 earnings conference call and webcast on Wednesday, February 11,...